☆ 4.7 Article

Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice

JOURNAL OF ETHNOPHARMACOLOGY (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Clinical Neurology

Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis

Kwonmok Ko et al.

Summary: Psychedelic therapy shows promising therapeutic effects on depressive symptoms according to recent clinical research. Psilocybin, ayahuasca, and LSD demonstrated significant reduction of symptoms in both short-term and long-term treatment.

JOURNAL OF AFFECTIVE DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms

Patrick D. Skosnik et al.

Summary: This study suggests that psilocybin has rapid and lasting antidepressant effects by promoting neuroplasticity. Comparing the effects of placebo and psilocybin, the researchers found that psilocybin increased neuroplasticity markers (theta power in EEG) and correlated with improvements in depression symptoms.

JOURNAL OF PSYCHOPHARMACOLOGY (2023)

添加到收藏夹

Article Mycology

Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development

R. C. Van Court et al.

Summary: Therapeutic use of psilocybin has gained attention in recent international research, highlighting the importance of understanding psilocybin-producing fungi for consumer safety.

FUNGAL BIOLOGY (2022)

添加到收藏夹

Article Psychiatry

Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice

Christopher W. Thomas et al.

Summary: Serotonergic psychedelic drugs, such as psilocin, affect sleep and vigilance state by delaying REM sleep onset, reducing NREM sleep maintenance, and enhancing 4 Hz cortical oscillation. However, these drugs do not significantly affect sleep-wake quantity and sleep recovery following sleep deprivation. Nevertheless, psilocin inhibits the recovery rate of sleep slow-wave activity in specific areas.

TRANSLATIONAL PSYCHIATRY (2022)

添加到收藏夹

Article Neurosciences

Tabernaemontana arborea and ibogaine induce paroxysmal EEG activity in freely moving mice: Involvement of serotonin 5-HT1A receptors

Maria Eva Gonzalez-Trujano et al.

Summary: This study evaluated the effect of Tabernaemontana arborea extract and its alkaloids on EEG activity in mice. The results showed that high doses of the extract induced abnormal EEG activity, partly due to the presence of ibogaine and involvement of serotonin 5-HT1A receptors. However, other constituents and mechanisms may also contribute to this excitatory activity, which should be explored in future studies.

NEUROTOXICOLOGY (2022)

添加到收藏夹

Article Psychiatry

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study

Federico Cavanna et al.

Summary: The use of low sub-perceptual doses of psychedelics, known as microdosing, has become popular in recent years. However, there is a lack of placebo-controlled studies on microdosing and its effects. A new study recruited individuals who were starting to microdose with psilocybin mushrooms and found that it had noticeable subjective effects and altered EEG rhythms, but without evidence to support enhanced well-being, creativity and cognitive function.

TRANSLATIONAL PSYCHIATRY (2022)

添加到收藏夹

Article Plant Sciences

Pharmacological and toxicological effects of Ruta chalepensis L. on experimentally induced seizures and electroencephalographic spectral power in mice

M. E. Gonzalez-Trujano et al.

Summary: The AcOEt fraction of R. chalepensis was found to be more effective than the aqueous extract in reducing tonic-clonic seizures and mortality in both PTZ and MES tests. The anticonvulsant effect of R. chalepensis does not appear to be mediated by GABA(A) receptors. However, caution is advised when using high doses of AcOEt as it may lead to neurotoxic effects.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT2A receptor activation

April Contreras et al.

Summary: This study demonstrates that hallucinogens modulate perception, emotion, and mood by targeting serotonin receptor (5-HTR), specifically the 5-HT2AR subtype. The administration of potent and highly selective 5-HT2AR agonist 25I-NBOH in mice leads to behavioral disorganization and frequent episodes of behavioral arrest, with specific EEG waveforms corresponding to these behaviors. Nicotine pretreatment attenuates some aspects of the response to 5-HT2AR activation induced by 25I-NBOH, suggesting that behavioral arrest and characteristic slow waveforms are key hallmarks of this response.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Medicine, General & Internal

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

Damian F. Santomauro et al.

Summary: This study aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020. The findings showed that the pandemic led to increased prevalence of major depressive disorder and anxiety disorders, with females and younger age groups being more affected. The pandemic has created an increased urgency to strengthen mental health systems in most countries and mitigation strategies are needed to address the burden of these mental disorders.

LANCET (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property

Guy A. Higgins et al.

Summary: Studies suggest that short-term administration of high psychedelic doses of serotonergic and dissociative hallucinogens like psilocybin and ketamine might have therapeutic potential for conditions such as major depressive disorder. Experiments using low doses of ketamine and psilocybin in rats show potential benefits in improving appetite, attention accuracy, and impulsive behavior.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors

Robertas Strumila et al.

Summary: Psilocybin, a psychedelic compound with a long history of human use, has the potential to modulate suicidal behaviors by targeting serotonin receptors and inflammation pathways. It can rapidly increase brain plasticity, suppress inflammation, and enhance cognitive flexibility, spirituality, and empathy, offering a promising approach for individuals at risk of suicide. This review highlights the possible mechanisms underlying psilocybin's positive effects on suicide risk and calls for further clinical studies in this area.

PHARMACEUTICALS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Therapeutic Potential of Psilocybin

Henry Lowe et al.

Summary: The psychedelic effects of certain plants and fungi have been intentionally utilized by humans for religious and spiritual purposes for centuries, with mushrooms serving as a primary source of naturally occurring psychedelics. Amidst negative stigma associated with psychedelic use, the U.S. government classified psychedelics as Schedule 1 drugs in 1970, impeding scientific research progress. Recent studies on the therapeutic potential of psilocybin in treating neuropsychiatric conditions have reignited interest and efforts in psilocybin research, leading to significant advances in understanding its chemical properties and uses.

MOLECULES (2021)

添加到收藏夹

Article Medicine, General & Internal

Trial of Psilocybin versus Escitalopram for Depression

Robin Carhart-Harris et al.

Summary: The study compared the efficacy of psilocybin and escitalopram in treating patients with major depressive disorder. While there was no significant difference in antidepressant effects between the two drugs at week 6, secondary outcomes generally favored psilocybin over escitalopram, though these results were not adjusted for multiple comparisons. Larger and longer trials are needed to further compare psilocybin with established antidepressants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice

Natalie Hesselgrave et al.

Summary: Psilocybin has shown promising rapid and persistent antidepressant effects in mice, possibly through enhancing excitatory synapses in the hippocampus, independent of 5-HT2A receptor activation. Further research is needed to explore the potential combination of psychedelic compounds and 5-HT2AR antagonists for clinical utility in human depression.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Psychiatry

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial

Alan K. Davis et al.

Summary: The study showed that psilocybin therapy with psychological support is effective in treating MDD, building on previous findings in patients with cancer and depression, as well as in a nonrandomized study in patients with treatment-resistant depression.

JAMA PSYCHIATRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in Magic Mushrooms

Felix Blei et al.

CHEMISTRY-A EUROPEAN JOURNAL (2020)

添加到收藏夹

Article Clinical Neurology

Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use

Carl A. Roberts et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials

Ana Sofia Vargas et al.

BIOMEDICINES (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Aqueous Extract of Pomegranate Alone or in Combination with Citalopram Produces Antidepressant-Like Effects in an Animal Model of Menopause: Participation of Estrogen Receptors

Brenda Valdes-Sustaita et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

添加到收藏夹

Article Behavioral Sciences

The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala

Alberto Hernandez-Leon et al.

BEHAVIOURAL PHARMACOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

Ricardo Jorge Dinis-Oliveira

DRUG METABOLISM REVIEWS (2017)

添加到收藏夹

Article Clinical Neurology

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

Alize J. Ferrari et al.

PLOS MEDICINE (2013)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Current findings, future trends, and unsolved problems in studies of medicinal mushrooms

Solomon P. Wasser

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Local sleep in awake rats

Vladyslav V. Vyazovskiy et al.

NATURE (2011)

添加到收藏夹

Review Medicine, Legal

Harm potential of magic mushroom use: A review

Jan van Amsterdam et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)

添加到收藏夹

Review Psychology, Clinical

The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress

Lakshmi N. Ravindran et al.

JOURNAL OF CLINICAL PSYCHIATRY (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions

Hasan Rafati et al.

INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS (2009)

添加到收藏夹

Review Pharmacology & Pharmacy

The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review

L Prut et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2003)

添加到收藏夹

Review Biochemistry & Molecular Biology

The pharmacology of psilocybin

T Passie et al.

ADDICTION BIOLOGY (2002)

添加到收藏夹

Article Chemistry, Medicinal

Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines

JB Blair et al.

JOURNAL OF MEDICINAL CHEMISTRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.